Skip to main content
Equibles

PLATINUM INVESTMENT MANAGEMENT LTD

Position in GPCR — Structure Therapeutics Inc.

CIK 1256071 SYDNEY AUSTRALIA 2000, C3
Back to GPCR Full portfolio

Position in GPCR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,849,782
+$1,626,938 QoQ
Shares Held
90,363
+35.1% QoQ
Ownership
0.127%
of shares outstanding
% of Portfolio
1.19%
of 13F equity value
Holder Rank
#62
of 190 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PLATINUM INVESTMENT MANAGEMENT LTD holds $78,056,040 across 25 Biotechnology names. GPCR ranks #7 (6.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 APGE
Apogee Therapeutics, Inc.
 58,314 $7,740,017
2 COGT
Cogent Biosciences, Inc.
 154,220 $5,968,314
3 IMVT
Immunovant, Inc.
 144,671 $5,574,173
4 ARWR
Arrowhead Pharmaceuticals, Inc.
 64,752 $5,277,935
5 IDYA
IDEAYA Biosciences, Inc.
 138,708 $5,169,647
6 VERA
Vera Therapeutics, Inc.
 113,687 $4,878,309
7 GPCR
Structure Therapeutics Inc.
This page 		90,363 $4,849,782
8 RCUS
Arcus Biosciences, Inc.
 134,217 $4,137,910

All Filings in GPCR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,849,782 90,363
2026-03-31 $3,222,844 66,864
2025-12-31 $6,111,636 87,874
2025-09-30 $3,437,224 122,758
2025-06-30 $1,553,426 74,900
2025-03-31 $1,296,519 74,900
2024-12-31 $2,031,288 74,900
2024-09-30 $2,511,824 57,230
2024-06-30 $2,247,422 57,230
2024-03-31 $3,304,205 77,093
2023-12-31 $3,142,310 77,093
2023-09-30 $2,645,083 52,461
2023-06-30 $623,550 15,000
2023-03-31 $356,850 15,000